Ventilator associated pneumonia in major paediatric burns

Alan David Rogers1, Cailin Deal2, Andrew Charles Argent3

  • 1Division of Plastic, Reconstructive and Maxillofacial Surgery, Groote Schuur Hospital and Red Cross War Memorial Children's Hospital, The University of Cape Town, Cape Town, South Africa.

Insights

Ventilator-associated pneumonia (VAP) significantly contributes to deaths in children with major burns. Early detection and strict prevention strategies are crucial for managing VAP in this vulnerable population.

Area of Science:

  • Pediatric critical care
  • Infectious disease epidemiology
  • Burn injury management

Background:

  • Infections, particularly ventilator-associated pneumonia (VAP), are a leading cause of mortality in major burn patients.
  • Pediatric burn injuries present unique challenges in infection control and management.

Purpose of the Study:

  • To investigate the incidence, risk factors, and outcomes of VAP in ventilated children with major burns.
  • To identify common etiological agents and evaluate diagnostic methods for VAP in this cohort.

Main Methods:

  • Retrospective analysis of 92 ventilated children with major burns over a five-year period.
  • Data collection included patient demographics, burn characteristics, ventilation duration, VAP episodes, and mortality.
  • Etiological agents were identified, and diagnostic method efficacy was assessed.

Main Results:

  • A VAP incidence rate of 30 infections per 1000 ventilator days was observed.
  • Prolonged ventilation and inhalational injury were significant risk factors for VAP.
  • Mortality was 17.4%, with pneumonia contributing to half of the deaths.
  • Streptococcus pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumanii, and Staphylococcus aureus were common pathogens.
  • Broncho-alveolar lavage demonstrated superior specificity and sensitivity for organism identification.

Conclusions:

  • VAP is a critical complication in pediatric major burn patients, significantly impacting mortality.
  • Implementing rigorous prevention, detection, and management strategies for VAP is essential.
  • Broncho-alveolar lavage is a valuable diagnostic tool in this patient population.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
1.3K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.7K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.8K